PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,815 | +59.7% | 91,758 | +108.6% | 0.01% | +75.0% |
| Q2 2023 | $1,763 | -5.0% | 43,994 | -3.2% | 0.00% | -20.0% |
| Q1 2023 | $1,856 | +2.1% | 45,470 | -3.4% | 0.01% | 0.0% |
| Q4 2022 | $1,817 | -99.9% | 47,063 | -0.6% | 0.01% | -28.6% |
| Q3 2022 | $2,520,000 | -3.2% | 47,369 | +6.1% | 0.01% | 0.0% |
| Q2 2022 | $2,602,000 | -6.0% | 44,639 | +23.1% | 0.01% | +40.0% |
| Q1 2022 | $2,768,000 | +26.9% | 36,262 | +0.0% | 0.01% | +25.0% |
| Q4 2021 | $2,181,000 | +8.4% | 36,250 | +0.9% | 0.00% | 0.0% |
| Q3 2021 | $2,012,000 | -7.9% | 35,933 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $2,184,000 | -13.5% | 35,990 | -0.1% | 0.00% | -33.3% |
| Q1 2021 | $2,525,000 | +17.3% | 36,032 | +0.2% | 0.01% | +20.0% |
| Q4 2020 | $2,152,000 | +1.0% | 35,960 | +1.5% | 0.01% | -16.7% |
| Q3 2020 | $2,131,000 | +15.2% | 35,441 | +0.5% | 0.01% | 0.0% |
| Q2 2020 | $1,850,000 | +57.7% | 35,256 | +0.8% | 0.01% | +50.0% |
| Q1 2020 | $1,173,000 | -22.1% | 34,974 | +5.3% | 0.00% | 0.0% |
| Q4 2019 | $1,505,000 | +19.8% | 33,228 | +0.7% | 0.00% | 0.0% |
| Q3 2019 | $1,256,000 | -28.8% | 33,002 | -14.6% | 0.00% | -50.0% |
| Q1 2017 | $1,763,000 | – | 38,653 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |